Rapid Dose Therapeutics Income Statement

Financials in millions CAD. Fiscal year is March - February.

Millions CAD. Fiscal year is Mar - Feb.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2020
Period Ending	Aug '25 Aug 31, 2025	Feb '25 Feb 28, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022	Feb '21 Feb 28, 2021	2018 - 2020
Revenue	2.63	2.09	1.02	0.72	1.75	0.76	Upgrade
Revenue Growth (YoY)	95.76%	104.34%	42.06%	-59.00%	131.98%	644.05%	Upgrade
Cost of Revenue	1.26	0.91	0.46	0.36	0.41	0.13	Upgrade
Gross Profit	1.36	1.18	0.56	0.36	1.34	0.63	Upgrade
Selling, General & Admin	3.34	3.55	2.45	2.46	2.99	1.5	Upgrade
Research & Development	0.1	0.15	0.43	0.09	0.36	0.09	Upgrade
Operating Expenses	4.77	5.35	3.65	3.9	5.65	2.26	Upgrade
Operating Income	-3.41	-4.17	-3.09	-3.54	-4.3	-1.63	Upgrade
Interest Expense	-1.19	-1.23	-0.66	-0.26	-0.13	-0.14	Upgrade
Interest & Investment Income	-	-	-	-	0	-	Upgrade
Currency Exchange Gain (Loss)	-	-	-	-0	0.02	-0.03	Upgrade
Other Non Operating Income (Expenses)	-	-	-	-	0.01	-	Upgrade
EBT Excluding Unusual Items	-4.6	-5.4	-3.75	-3.81	-4.4	-1.81	Upgrade
Impairment of Goodwill	-	-	-	-	-4.08	-	Upgrade
Other Unusual Items	-	-	-0.56	-	-	-	Upgrade
Pretax Income	-4.6	-5.4	-4.31	-3.81	-8.49	-1.81	Upgrade
Net Income	-4.6	-5.4	-4.31	-3.81	-8.49	-1.81	Upgrade
Net Income to Common	-4.6	-5.4	-4.31	-3.81	-8.49	-1.81	Upgrade
Shares Outstanding (Basic)	140	125	105	103	100	78	Upgrade
Shares Outstanding (Diluted)	140	125	105	103	100	78	Upgrade
Shares Change (YoY)	33.83%	18.68%	1.50%	3.19%	28.83%	2.23%	Upgrade
EPS (Basic)	-0.03	-0.04	-0.04	-0.04	-0.08	-0.02	Upgrade
EPS (Diluted)	-0.03	-0.04	-0.04	-0.04	-0.08	-0.02	Upgrade
Free Cash Flow	-1.06	-1.15	-2.29	-0.86	-3.04	-1.63	Upgrade
Free Cash Flow Per Share	-0.01	-0.01	-0.02	-0.01	-0.03	-0.02	Upgrade
Gross Margin	51.92%	56.59%	55.21%	49.67%	76.76%	83.40%	Upgrade
Operating Margin	-129.74%	-200.07%	-302.45%	-493.36%	-245.55%	-216.45%	Upgrade
Profit Margin	-175.00%	-259.18%	-422.03%	-530.42%	-484.47%	-239.04%	Upgrade
Free Cash Flow Margin	-40.20%	-55.27%	-224.91%	-120.27%	-173.52%	-216.20%	Upgrade
EBITDA	-3.05	-3.95	-2.75	-3.2	-3.82	-1.25	Upgrade
EBITDA Margin	-116.29%	-189.66%	-269.93%	-	-218.31%	-165.21%	Upgrade
D&A For EBITDA	0.35	0.22	0.33	0.34	0.48	0.39	Upgrade
EBIT	-3.41	-4.17	-3.09	-3.54	-4.3	-1.63	Upgrade
EBIT Margin	-129.74%	-200.07%	-	-	-245.55%	-216.45%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.